NCT07237412Recruiting
Neurofeedback-based Visual Restoration Therapy
Source: ClinicalTrials.gov · Last updated 29 Apr 2026
Brief summary (registry, in English)
Visual field defects are a common consequence of acquired brain injuries and affect people of all ages. These vision problems make everyday life more difficult-for example, when reading, driving, or moving around safely. However, there is currently no effective therapy to improve visual field defects. Previous training methods have focused on maximizing brain activity during a task. However, new findings show that the best performance is achieved when the brain is already in a state of high communication before the task. Our research shows that people can learn to increase communication between brain regions through neurofeedback. Studies have shown that neurofeedback can help people after a stroke: it improves the coordination of brain areas that are important for movement, thereby helping to increase mobility. Building on these findings, this study investigates whether EEG neurofeedback can support the visual centers in the brain to improve vision in patients with chronic visual field defects. The main objective of the study is to evaluate the effectiveness of neurofeedback in improving visual field defects. More specifically, the investigators are investigating the development of visual ability (expansion of the visual field, contrast sensitivity).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 14 (estimated)
- First submitted
- 14 Nov 2025
- Start date
- 17 Nov 2025
- Primary completion date
- 30 Apr 2028
- Lead sponsor
- Adrian Guggisberg
- Diseases
- Stroke
- NCT number
- NCT07237412
What you commit to
- Study type: Interventional
- Planned participants: 14
- From 17 Nov 2025 to the primary completion date, 30 Apr 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Eye disease with impact on visual field or acuity
- New stroke during study period
Other
- Inability to concentrate for long treatment sessions
- Presence of non-MRI safe metal in the body
- Hemispatial neglect
Who the study is looking for
- Chronic, stable HVFD (homologous lateral quadranopsia or hemianopsia)
- 12 months or more after stroke
- Age range 50-70
- Ability to provide informed consent
Age in the registry: 50 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Inselspital Coordinator of this site? Confirm its status | Bern | Switzerland | Recruiting |
| Division of Neurorehabilitation, University Hospital of Geneva Coordinator of this site? Confirm its status | Geneva | Switzerland | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.